{"id":"fms-azithromycin-tablets","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Diarrhea"},{"rate":"3-5","effect":"Nausea"},{"rate":"2-4","effect":"Abdominal pain"},{"rate":"1-3","effect":"Vomiting"},{"rate":"rare","effect":"QT prolongation"},{"rate":"rare","effect":"Hepatotoxicity"}]},"_chembl":{"chemblId":"CHEMBL4299381","moleculeType":"Small molecule","molecularWeight":"749.00"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Azithromycin binds to the bacterial 50S ribosomal subunit and inhibits peptide translocation, preventing the formation of the initiation complex and blocking bacterial protein synthesis. This bacteriostatic action is effective against a broad spectrum of gram-positive and gram-negative bacteria, as well as some atypical organisms. The drug accumulates in tissues and has a long half-life, allowing for extended dosing intervals.","oneSentence":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:30:09.471Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections including respiratory tract infections, skin and soft tissue infections, and sexually transmitted infections"},{"name":"Otitis media and sinusitis"}]},"trialDetails":[{"nctId":"NCT02215460","phase":"PHASE4","title":"Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours","status":"COMPLETED","sponsor":"University of Taubate","startDate":"2012-04","conditions":"Periodontitis","enrollment":130}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"FMS azithromycin tablets","genericName":"FMS azithromycin tablets","companyName":"University of Taubate","companyId":"university-of-taubate","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Bacterial infections including respiratory tract infections, skin and soft tissue infections, and sexually transmitted infections, Otitis media and sinusitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}